Buscar
Mostrando ítems 1-10 de 171
Atrofia vellositaria duodenal inducida por micofenolato mofetil: Caso clínico
(Sociedad Médica de Santiago, 2010)
Mycophenolate mofetil substitution for cyclosporine A in renal transplant recipients with chronic progressive allograft dysfunction: the creeping creatinine study
(Lippincott Williams & Wilkins, 2005-02-27)
Background. This study determined whether cyclosporine A (CsA)-treated renal allograft recipients with deteriorating renal function (creeping creatinine) secondary to chronic allograft nephropathy (CAN) benefit from the ...
Mycophenolate mofetil versus Rapamycin in Han: SPRD rats with Polycystic Kidney Disease
(Sociedad de Biología de Chile, 2009)
Randomized crossover study to assess the inter- and intrasubject variability of morning mycophenolic acid concentrations from enteric-coated mycophenolate sodium and mycophenolate mofetil in stable renal transplant recipients
(Wiley-Blackwell, 2010-07-01)
The delayed release of mycophenolic acid (MPA) from enteric-coated mycophenolate sodium (EC-MPS, myfortic (R)) may have an impact on the variability of MPA trough (C(0 h)) levels. A randomized, two-period crossover study ...
Relative bioavailability study of two oral formulations of mycophenolate mofetil in healthy volunteers Estudio de biodisponibilidad relativa entre dos formulaciones orales de micofenolato mofetilo en voluntarios sanos
(2011)
Background: The bioequivalence of different formulations of a same pharmaceutical product must be tested empirically. Aim: To evaluate the relative bioavailability for an oral formulation of mycophenolate mofetil (MMF) ...
Influence of mycophenolate mofetil on gastrointestinal motility evaluated in renal transplant patients by a biomagnetic technique
(Lippincott Williams & Wilkins, 2014-07-15)